Respironics Investors Breathing Easy After Turnaround; Stock Up 25% In Nov.
This article was originally published in The Gray Sheet
Executive Summary
An accelerating growth rate and positive news highlighted at Respironics' Nov. 16 annual shareholder meeting breathed new life into the company's stock price. The issue closed Nov. 30 at $24.56, up $4.93, or 25.1%, for the month.